
MPLT EPS Estimates
MapLight Therapeutics, Inc.
$5.94
-$0.48(-7.48%)
36
Overall
60
Value
36
Tech
13
Quality
Market Cap
$275.48M
Volume
357.94K
52W Range
$6.06 - $40.43
Target Price
$27.15
MPLT EPS estimates: the consensus estimate for MapLight Therapeutics, Inc.'s current fiscal year is -$5.01 per share. Quarterly and next-year EPS forecasts, growth estimates and revenue projections follow.
MPLT EPS Estimates
- EPS estimate, current quarter
- $-1.22
- EPS estimate, next quarter
- $-1.15
- EPS estimate, current year
- $-5.01
- EPS estimate, next year
- $-4.12
- EPS growth, 3-year
- -79.48%
| Fiscal year | EPS |
|---|---|
| 2025 | $-18.56 |
| 2024 | $-105.38 |
| 2023 | $-5.03 |
| 2022 | $-3.21 |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | MPLT | $5.94 | -7.5% | 357.94K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get MapLight Therapeutics, Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW